Quantum Biopharma Ltd Cls B Subordinate Voting S (QNTM.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 491 | 2,506 | 4,535 | 4,046 | 3,900 |
| Accounts receivable | 4,517 | -729 | -7,216 | -107 | 435 |
| Other Working Capital | 9,757 | 1,638 | -7,120 | 2,889 | 807 |
| Other Operating Activity | -21,641 | -14,243 | -18,531 | -27,574 | -24,273 |
| Operating Cash Flow | $-6,876 | $-10,827 | $-28,333 | $-20,746 | $-19,130 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | -114 | N/A | N/A |
| Net Acquisitions | 0 | 32 | 0 | 769 | 0 |
| Purchase Of Investment | -7,693 | -745 | -402 | N/A | N/A |
| Sale Of Investment | 6,189 | 443 | 158 | 0 | 6,478 |
| Purchase Sale Intangibles | 0 | 0 | -250 | -500 | 0 |
| Other Investing Activity | 0 | 0 | 12,731 | 0 | 37 |
| Investing Cash Flow | $-1,504 | $-270 | $12,123 | $269 | $6,514 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,012 | 0 | 0 | -72 | N/A |
| Debt Repayment | -64 | -189 | -143 | -58 | -987 |
| Common Stock Issued | 10,671 | 0 | 0 | 38,341 | 25,100 |
| Common Stock Repurchased | 0 | -2,958 | -1,926 | N/A | N/A |
| Other Financing Activity | 0 | 20 | 0 | 0 | 60 |
| Financing Cash Flow | $11,619 | $-3,127 | $-2,069 | $38,212 | $24,173 |
| Beginning Cash Position | 2,757 | 16,980 | 35,260 | 17,525 | 5,968 |
| End Cash Position | 5,996 | 2,757 | 16,980 | 35,260 | 17,525 |
| Net Cash Flow | $3,239 | $-14,223 | $-18,279 | $17,735 | $11,557 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,876 | -10,827 | -28,333 | -20,746 | -19,130 |
| Capital Expenditure | N/A | N/A | -364 | -500 | N/A |
| Free Cash Flow | -6,876 | -10,827 | -28,697 | -21,246 | -19,130 |